PROCEPT BioRobotics (PRCT) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 4, 2026

Source: earnings call transcript

PROCEPT BioRobotics delivered strong HYDROS system sales and record pricing in Q2 FY26, but overall procedure growth was softer than anticipated due to underperformance in legacy AQUABEAM accounts. The company is accelerating its AQUABEAM to HYDROS upgrade program and scaling its dedicated launch teams to drive utilization, while reaffirming full-year revenue and gross margin guidance and maintaining its target for positive adjusted EBITDA in Q4 FY26.

You’re reading a preview. Opening the full call uses 1 concall credit.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.